Company intelligence / Profile preview

SIGAL SMS

Leipzig, Saxony, Germanysigal-sms.de ↗

Ownership: Private
Development stage: Other

Overview

SIGAL SMS operates a network of approximately 25 outpatient study sites across Germany, supporting physicians in private practice with the implementation and management of clinical trials. The company specializes in optimizing site performance, accelerating study start-up and recruitment timelines, and providing structured processes for feasibility analysis, project management, contracting, and patient recruitment. Its network covers more than 25 therapeutic areas with access to over 688,000 patients[1][2][4].

Industry: Contract Research Organization

Partnerships

Partnerships with research-based pharmaceutical companiesPartnerships with biotech companies

Beyond the preview

Go deeper on SIGAL SMS.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SIGAL SMS.

Explore the full profile